seo
I think another one is that actually it's really hard were biology is very complex and when you get into these I diseases a Beijing an all-out the process sees that you're trying to affect its it's very difficult to do it and effective manner and you know if there's a problem if you start to develop something like a anti-age me aging alpha zxt medicines or something in the clinical process is now up its eight years so there's a real lag time between the time that you have something that’s innovative and the time that it can actually get through the clinic and get the people and you know that may not have the same impact on uploading sent to already be clinically dead but it wouldn't surprise me if the FDA would want to get involved in that as well um so you have to wonder at least I do whether a.